(Q55068244)

English

Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients.

scientific article published in January 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9927168

Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients. (English)

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9927168

liver cirrhosis

0 references

hepatorenal syndrome

1 reference

based on heuristic

inferred from title

author name string

Kaffy F

1

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9927168

Borderie C

2

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9927168

Chagneau C

3

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9927168

Ripault MP

4

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9927168

Larzillière I

5

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9927168

Silvain C

6

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9927168

Beauchant M

7

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9927168

publication date

1 January 1999

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9927168

Journal of Hepatology

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9927168

30

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9927168

1

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9927168

174

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9927168

Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatorenal syndrome. Long-term treatment with terlipressin as a bridge to liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(99)80025-7

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9927168

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/9927168

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55068244&oldid=1517031245"